|
|
||||||||
Torrey Pines Institute for Molecular Studies, San Diego, CA 92121
Previous studies focused on indels in the complement C345 protein
family identified a number of potential protein-protein interaction
sites in components C3 and C5. Here, one of these sites in C5, near the
-chain C terminus, was examined by alanine-scanning mutagenesis at
16 of the 18 non-alanine residues in the sequence
KEALQIKYNFSFRYIYPLD. Alanine substitutions affected
activities in the highly variable manner characteristic of binding
sites. Substitutions at the lysine or either phenylalanine residue in
the central KYNFSF sequence had the greatest effects, yielding mutants
with <20% of the normal activity. These three mutants were also
resistant to the classical pathway (CP) C5 convertase, with
sensitivities roughly proportional to their hemolytic activities, but
had normal susceptibilities to the cobra venom factor (CVF)-dependent
convertase. Synthetic peptide MGKEALQIKYNFS-NH2 was found
similarly to inhibit CP but not CVF convertase activation, and the
effects of alanine substitutions in this peptide largely reflected
those of the equivalent mutations in C5. These results indicate that
residues KYNFSF form a novel, distal binding site for the CP, but not
CVF convertase. This site lies
880 residues downstream of the
convertase cleavage site within a module that has been independently
named C345C and NTR; this module is found in diverse proteins including
netrins and tissue inhibitors of
metalloproteinases.
This article has been cited by other articles:
![]() |
J. Bramham, C.-T. Thai, D. C. Soares, D. Uhrin, R. T. Ogata, and P. N. Barlow Functional Insights from the Structure of the Multifunctional C345C Domain of C5 of Complement J. Biol. Chem., March 18, 2005; 280(11): 10636 - 10645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nunn, A. Sharma, G. C. Paesen, S. Adamson, O. Lissina, A. C. Willis, and P. A. Nuttall Complement Inhibitor of C5 Activation from the Soft Tick Ornithodoros moubata J. Immunol., February 15, 2005; 174(4): 2084 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Thai and R. T. Ogata Expression and Characterization of the C345C/NTR Domains of Complement Components C3 and C5 J. Immunol., December 15, 2003; 171(12): 6565 - 6573. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rawal and M. K. Pangburn Formation of High Affinity C5 Convertase of the Classical Pathway of Complement J. Biol. Chem., October 3, 2003; 278(40): 38476 - 38483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Inal and J. A. Schifferli Complement C2 Receptor Inhibitor Trispanning and the {beta}-Chain of C4 Share a Binding Site for Complement C2 J. Immunol., May 15, 2002; 168(10): 5213 - 5221. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rawal and M. K. Pangburn Formation of High-Affinity C5 Convertases of the Alternative Pathway of Complement J. Immunol., February 15, 2001; 166(4): 2635 - 2642. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |